Kinesiotaping and Stretching on SKM and Upper Trapezius Muscle in TMD Patients
Comparative Efficacy of Kinesiotaping and Stretching on Sternocleidomastoid and Upper Trapezius Muscles in Patients Suffering From Myofascial Pain Due to Temporomandibular Joint Disorder
1 other identifier
interventional
33
1 country
1
Brief Summary
Purpose: This study determined the effects of Kinesiotaping and Stretching on pain, cervical joint range of motion and functional status in patients with myofascial pain due to temporomandibular joint disorder. Methods: 33 patients with myofascial pain due to temporomandibular joint disorder were included in the study. The patients were divided into three groups by simple randomization (Kinesiotaping group, Stretching group and Control group). Patients in the Kinesiotaping and Stretching groups received application for their Upper Trapezius and Sternocleidomastoid muscles twice a week for two weeks by the same physiotherapist. No application was made to the Control group. Cervical joint range of motion, muscle strength and pain were evaluated. Additionally, algometry tests and functional evaluation were performed. The tests were performed in the Kinesiotaping and Stretching groups before the applications and at the end of week 1 and week 2, on the other hand Control group evaluated before the application and at the end of week 2.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 15, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 19, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 19, 2018
CompletedFirst Submitted
Initial submission to the registry
July 27, 2022
CompletedFirst Posted
Study publicly available on registry
August 1, 2022
CompletedAugust 1, 2022
July 1, 2022
4 months
July 27, 2022
July 29, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Pain Intensity
The subjective pain intensity of the patients was assessed with the Visual Analogue Scale. The Visual Analog Scale includes scoring between 0 and 10. The corresponding numbers from 0 to 10 were explained to the patients. It was explained that the absence of pain was 0, the most severe pain felt was 10, and moderate pain was 5. For the Upper Trapezius and SCM muscle, the patients were asked to mark their resting and functional pain from the scale.Additionally, pain during palpation of the upper trapezius and sternocleidomastoid muscle was assessed with algometry.
2 weeks
Range of Motion
The range of motion of the cervical joint was assessed using a goniometer
2 weeks
Research Diagnostic Criteria for Temporomandibular Disorders
Klinik değerlendirme formunun içeriğinde ağrının nedeni ve ağrının tarafı, ağız açılma şekli ve açılma miktarı, eklem sesleri, eksantrik hareket miktarları ve hareket sırasındaki ağrı durumları, eklem sesleri ve kas ağrıları palpasyonla değerlendirildi. .
2 week
Muscle Strength
Cervical muscle strength was assessed manually
2 week
Mouth Opening Distance
The mouth opening of the patients was measured in millimeters for the distance between anterior incisors of the upper and lower jaws.
2 weeks
Secondary Outcomes (2)
The Patient Health Questionnaire
2 weeks
Jaw Functional Limitation Scale
2 weeks
Study Arms (3)
Kinesiotaping Group
EXPERIMENTALIn the Kinesiotaping Group patients had muscle technique-inhibition method. An 'I' shaped tape was used for both SCM and upper trapezius.
Stretching Group
EXPERIMENTALThe patient was stretched in a relaxed and supported position and physiotherapist positioned the patient passively for stretching.
Control Group
OTHERControl Group patients, after the assessment by the dentist, the treatment method approved by the dentist was performed.
Interventions
In the Kinesiotaping Group patients had muscle technique-inhibition method. An 'I' shaped tape was used for both SCM and upper trapezius. The tension of the tape was adjusted between 20 and 25% and the application was performed in the longest position of the muscle. The inhibition technique was applied from the insertion to the origin of the muscle. The tape was applied to cover the trigger points where pain was felt. For upper trapezius, the muscle was taped in the opposite direction on the cervical region in lateral flexion, slight flexion, shoulder depression and using the muscle technique with the I tape. For SCM muscle, the tape was applied on the muscle in the opposite direction on the cervical region with positioning in lateral flexion, extension and ipsilateral rotation using the muscle technique with I tape Taping was applied every 3 days and totally in 4 cycles.
In our application, 3 cycles of 20 seconds of stretches were applied to upper trapezius and SCM muscle. The patient was stretched in a relaxed and supported position and physiotherapist positioned the patient passively for stretching. For the SCM muscle, stretching was achieved in the positions of contralateral lateral flexion, ipsilateral rotation and extension. For upper trapezius, stretching was performed in flexion and lateral flexion. Stretching was performed every 3 days in 4 cycles in total.
Control Group patients, after the assessment by the dentist, the treatment method approved by the dentist was performed. The assessment was performed before treatment, at the end of week 1 and at the end of week 2.
Eligibility Criteria
You may qualify if:
- Age between 18 and 60 years
- Myofascial pain according to RDC/TMD
- Natural posterior occlusion and volunteering
- Being informed and signing the consent to participate in the research.
You may not qualify if:
- Presence of dentofacial anomalies
- Arthralgia
- Disk displacement
- General inflammatory connective tissue diseases (e.g. rheumatoid arthritis)
- Psychiatric disease
- Tumor
- Orofacial disease symptoms (neuralgia, migraine, etc.)
- Local skin infection
- Using regular analgesic
- Fibromyalgia
- History of TMJ-related surgery
- Findings of allergy related to Kinesiotape.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Arel University
Istanbul, Turkey (Türkiye)
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ozge Baykan Copuroglu, MSc
Istanbul Arel University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prelector/ Physiotherapist
Study Record Dates
First Submitted
July 27, 2022
First Posted
August 1, 2022
Study Start
March 15, 2018
Primary Completion
July 19, 2018
Study Completion
July 19, 2018
Last Updated
August 1, 2022
Record last verified: 2022-07